Saracatinib Inhibits Middle East Respiratory Syndrome-Coronavirus Replication In Vitro
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Saracatinib Inhibits Middle East Respiratory Syndrome-Coronavirus Replication In Vitro
Authors
Keywords
-
Journal
Viruses-Basel
Volume 10, Issue 6, Pages 283
Publisher
MDPI AG
Online
2018-05-28
DOI
10.3390/v10060283
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Coronavirus S protein-induced fusion is blocked prior to hemifusion by Abl kinase inhibitors
- (2018) Jeanne M. Sisk et al. JOURNAL OF GENERAL VIROLOGY
- Tyrosine kinase inhibitors: potential use and safety considerations in HIV-1 infection
- (2017) Mayte Coiras et al. Expert Opinion On Drug Safety
- Evaluation and Clinical Validation of Two Field–Deployable Reverse Transcription-Insulated Isothermal PCR Assays for the Detection of the Middle East Respiratory Syndrome–Coronavirus
- (2017) Yun Young Go et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- c-SRC protein tyrosine kinase regulates early HIV-1 infection post-entry
- (2016) Stephen D.S. McCarthy et al. AIDS
- Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion
- (2016) Christopher M. Coleman et al. JOURNAL OF VIROLOGY
- Coronaviruses — drug discovery and therapeutic options
- (2016) Alimuddin Zumla et al. NATURE REVIEWS DRUG DISCOVERY
- SARS and MERS: recent insights into emerging coronaviruses
- (2016) Emmie de Wit et al. NATURE REVIEWS MICROBIOLOGY
- Identification and characterization of the role of c-terminal Src kinase in dengue virus replication
- (2016) Rinki Kumar et al. Scientific Reports
- Synergistic antiviral activity of gemcitabine and ribavirin against enteroviruses
- (2015) Hyunju Kang et al. ANTIVIRAL RESEARCH
- Middle East Respiratory Syndrome Coronavirus: Another Zoonotic Betacoronavirus Causing SARS-Like Disease
- (2015) Jasper F. W. Chan et al. CLINICAL MICROBIOLOGY REVIEWS
- Hck Inhibitors as Potential Therapeutic Agents in Cancer and HIV Infection
- (2015) F. Musumeci et al. CURRENT MEDICINAL CHEMISTRY
- Middle East respiratory syndrome
- (2015) Alimuddin Zumla et al. LANCET
- 2014 MERS-CoV Outbreak in Jeddah — A Link to Health Care Facilities
- (2015) Ikwo K. Oboho et al. NEW ENGLAND JOURNAL OF MEDICINE
- Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture
- (2014) Adriaan H. de Wilde et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antiviral Potential of ERK/MAPK and PI3K/AKT/mTOR Signaling Modulation for Middle East Respiratory Syndrome Coronavirus Infection as Identified by Temporal Kinome Analysis
- (2014) Jason Kindrachuk et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection
- (2014) Julie Dyall et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Transmission of MERS-Coronavirus in Household Contacts
- (2014) Christian Drosten et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evidence for Camel-to-Human Transmission of MERS Coronavirus
- (2014) Esam I. Azhar et al. NEW ENGLAND JOURNAL OF MEDICINE
- What are our pharmacotherapeutic options for MERS-CoV?
- (2014) Jaffar A Al-Tawfiq et al. Expert Review of Clinical Pharmacology
- Identification of Hck Inhibitors As Hits for the Development of Antileukemia and Anti-HIV Agents
- (2013) Cristina Tintori et al. ChemMedChem
- Interferon- and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays
- (2013) B. J. Hart et al. JOURNAL OF GENERAL VIROLOGY
- The emerging novel Middle East respiratory syndrome coronavirus: The “knowns” and “unknowns”
- (2013) Jasper Fuk-Woo Chan et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- The Small Molecules AZD0530 and Dasatinib Inhibit Dengue Virus RNA Replication via Fyn Kinase
- (2013) M. de Wispelaere et al. JOURNAL OF VIROLOGY
- Obatoclax, Saliphenylhalamide, and Gemcitabine Inhibit Influenza A Virus Infection
- (2012) Oxana V. Denisova et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic?
- (2012) Jasper F.W. Chan et al. JOURNAL OF INFECTION
- The ephrin receptor tyrosine kinase A2 is a cellular receptor for Kaposi's sarcoma–associated herpesvirus
- (2012) Alexander S Hahn et al. NATURE MEDICINE
- Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
- (2012) Ali M. Zaki et al. NEW ENGLAND JOURNAL OF MEDICINE
- Receptor Tyrosine Kinase Inhibitors That Block Replication of Influenza A and Other Viruses
- (2011) Naveen Kumar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- C-Src is required for complex formation between the hepatitis C virus-encoded proteins NS5A and NS5B: A prerequisite for replication
- (2011) Andreas Pfannkuche et al. HEPATOLOGY
- Tyrosine kinase receptor Axl enhances entry of Zaire ebolavirus without direct interactions with the viral glycoprotein
- (2011) Melinda A. Brindley et al. VIROLOGY
- Exploiting Drug Repositioning for Discovery of a Novel HIV Combination Therapy
- (2010) C. L. Clouser et al. JOURNAL OF VIROLOGY
- Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapy
- (2010) J Rafael Sierra et al. Molecular Cancer
- ABL Tyrosine Kinases: Evolution of Function, Regulation, and Specificity
- (2010) J. Colicelli Science Signaling
- The Epidermal Growth Factor Receptor (EGFR) Promotes Uptake of Influenza A Viruses (IAV) into Host Cells
- (2010) Thorsten Eierhoff et al. PLoS Pathogens
- Specific Cross-talk between Epidermal Growth Factor Receptor and Integrin αvβ5 Promotes Carcinoma Cell Invasion and Metastasis
- (2009) Jill M. Ricono et al. CANCER RESEARCH
- The Tyrosine Kinase c-Src Enhances RIG-I (Retinoic Acid-inducible Gene I)-elicited Antiviral Signaling
- (2009) Ingvild B. Johnsen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530
- (2009) Tim P. Green et al. Molecular Oncology
- Targeting Src in breast cancer
- (2008) R. S. Finn ANNALS OF ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started